ATE140026T1 - Verfahren zur herstellung von thrombin und danach erhaltene hochgereinigte thrombinzusammensetzung - Google Patents
Verfahren zur herstellung von thrombin und danach erhaltene hochgereinigte thrombinzusammensetzungInfo
- Publication number
- ATE140026T1 ATE140026T1 AT91100853T AT91100853T ATE140026T1 AT E140026 T1 ATE140026 T1 AT E140026T1 AT 91100853 T AT91100853 T AT 91100853T AT 91100853 T AT91100853 T AT 91100853T AT E140026 T1 ATE140026 T1 AT E140026T1
- Authority
- AT
- Austria
- Prior art keywords
- thrombin
- composition obtained
- highly purified
- obtained therefrom
- producing
- Prior art date
Links
- 108090000190 Thrombin Proteins 0.000 title abstract 6
- 229960004072 thrombin Drugs 0.000 title abstract 6
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229920000936 Agarose Polymers 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 108010094028 Prothrombin Proteins 0.000 abstract 1
- 102100027378 Prothrombin Human genes 0.000 abstract 1
- 108010000499 Thromboplastin Proteins 0.000 abstract 1
- 102000002262 Thromboplastin Human genes 0.000 abstract 1
- 238000005349 anion exchange Methods 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 238000005341 cation exchange Methods 0.000 abstract 1
- 238000007865 diluting Methods 0.000 abstract 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 230000023597 hemostasis Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008363 phosphate buffer Substances 0.000 abstract 1
- 239000002953 phosphate buffered saline Substances 0.000 abstract 1
- 229940039716 prothrombin Drugs 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE26690A IE73210B1 (en) | 1990-01-24 | 1990-01-24 | Process for the production of thrombin and high purity thrombin preparation thereby obtained |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE140026T1 true ATE140026T1 (de) | 1996-07-15 |
Family
ID=11009586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91100853T ATE140026T1 (de) | 1990-01-24 | 1991-01-23 | Verfahren zur herstellung von thrombin und danach erhaltene hochgereinigte thrombinzusammensetzung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5151355A (de) |
| EP (1) | EP0439156B1 (de) |
| JP (1) | JP3276964B2 (de) |
| AT (1) | ATE140026T1 (de) |
| CA (1) | CA2034826A1 (de) |
| DE (1) | DE69120550D1 (de) |
| IE (1) | IE73210B1 (de) |
| ZA (1) | ZA91500B (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5281528A (en) * | 1989-12-18 | 1994-01-25 | Warner-Lambert Company | Process for purified thromboplastin for ultra-pure thrombin preparation |
| AU642987B2 (en) * | 1991-03-25 | 1993-11-04 | Warner-Lambert Company | Ultra-pure thrombin preparation |
| EP0505604B1 (de) * | 1991-03-28 | 1996-09-25 | Warner-Lambert Company | Hochreine Thrombinzubereitung |
| AT402891B (de) * | 1991-06-20 | 1997-09-25 | Immuno Ag | Verfahren zur herstellung eines inaktivierten blutproduktes |
| FR2679251B1 (fr) * | 1991-07-18 | 1993-11-12 | Nord Assoc Essor Transfusion San | Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique. |
| AT398079B (de) * | 1991-11-04 | 1994-09-26 | Immuno Ag | Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung |
| DE4137996A1 (de) * | 1991-11-19 | 1993-05-27 | Behringwerke Ag | Verfahren zur herstellung eines virussicheren thrombinkonzentrates |
| AT397390B (de) * | 1992-04-06 | 1994-03-25 | Immuno Ag | Verfahren zur spaltung von proteinen |
| US5792623A (en) * | 1992-04-06 | 1998-08-11 | Immuno Aktiengesellschaft | Method for producing activated blood factors with a protease and a detergent |
| AT399818B (de) * | 1992-04-24 | 1995-07-25 | Immuno Ag | Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation |
| DK83092D0 (da) * | 1992-06-24 | 1992-06-24 | Unes As | Fremgangsmaade til udvinding af thrombin |
| WO1994013329A1 (de) * | 1992-12-16 | 1994-06-23 | Immuno Aktiengesellschaft | Verfahren zur herstellung eines virussicheren biologischen präparates |
| DE4320294A1 (de) * | 1993-06-18 | 1994-12-22 | Immuno Ag | Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen |
| US5795780A (en) * | 1993-06-23 | 1998-08-18 | Bristol-Myers Squibb Company | Method of use of autologous thrombin blood fraction in a cell culture with keratinocytes |
| JPH07308190A (ja) * | 1994-05-18 | 1995-11-28 | Green Cross Corp:The | トロンビンの製造方法 |
| US5506127A (en) * | 1994-09-21 | 1996-04-09 | Proba; Zbigniew | Therapeutic grade thrombin produced by chromatography |
| US5677162A (en) * | 1995-05-01 | 1997-10-14 | New York Blood Center, Inc. | Method for activating prothrombin to thrombin |
| WO2000062828A1 (en) | 1996-04-30 | 2000-10-26 | Medtronic, Inc. | Autologous fibrin sealant and method for making the same |
| US6168788B1 (en) | 1997-09-26 | 2001-01-02 | Leon Wortham | Fibrin glue without fibrinogen and biosealant compositions and methods |
| US6274090B1 (en) | 1998-08-05 | 2001-08-14 | Thermogenesis Corp. | Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| US6472162B1 (en) | 1999-06-04 | 2002-10-29 | Thermogenesis Corp. | Method for preparing thrombin for use in a biological glue |
| DE10012732A1 (de) * | 2000-03-18 | 2001-09-20 | Aventis Behring Gmbh | Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung |
| GB0216002D0 (en) * | 2002-07-10 | 2002-08-21 | Nat Blood Authority | Process and composition |
| US20040243044A1 (en) * | 2003-06-02 | 2004-12-02 | Penegor Stephen A. | Hemostatic wound dressing |
| US20060270015A1 (en) * | 2005-05-26 | 2006-11-30 | Dan Pawlak | Thrombin purification |
| US20060270014A1 (en) * | 2005-05-26 | 2006-11-30 | Dan Pawlak | Thrombin purification |
| US9932388B2 (en) | 2014-11-13 | 2018-04-03 | Hemarus Therapeutics Limited | Chromatographic process for producing high purity fibrinogen and thrombin |
| EP3262409B1 (de) * | 2015-02-25 | 2020-03-25 | Omrix Biopharmaceuticals Ltd. | Verfahren zur reinigung und quantifizierung von thrombin und seinen abbaupolypeptiden |
| ES2791982T3 (es) * | 2015-02-25 | 2020-11-06 | Omrix Biopharmaceuticals Ltd | Método para purificar y cuantificar la trombina y sus polipéptidos de degradación |
| EP3934542A1 (de) | 2019-03-06 | 2022-01-12 | Gambro Lundia AB | Vorrichtung und verfahren zur abgabe eines thrombinaktivierten fibrinversiegelers |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE265329C (de) * | ||||
| US4286056A (en) * | 1980-01-28 | 1981-08-25 | Baxter Travenol Laboratories, Inc. | Method for making therapeutic enzyme compositions |
| US4363319A (en) * | 1980-06-30 | 1982-12-14 | Applied Medical Devices, Inc. | Ready-to-use bandage incorporating a coagulant composition and method of preparing same |
| US4380511A (en) * | 1981-08-12 | 1983-04-19 | Miles Laboratories, Inc. | Purification of bovine thrombin |
| US4470969A (en) * | 1983-12-02 | 1984-09-11 | Miles Laboratories, Inc. | Process for producing a concentrate of coagulation factors VII and VIIa |
| US4473553A (en) * | 1983-12-02 | 1984-09-25 | Miles Laboratories, Inc. | Process for producing a lipoprotein-poor concentrate of coagulation factors VII and VIIa |
| NO164991C (no) * | 1984-09-21 | 1990-12-05 | Boehringer Ingelheim Int | Fremgangsmaate for fremstilling av blodkoaguleringshemmende proteiner. |
| US4637932A (en) * | 1984-10-15 | 1987-01-20 | Miles Laboratories, Inc. | Process for producing a concentrate enriched in coagulation factors VII and VIIa |
| US4696812A (en) * | 1985-10-28 | 1987-09-29 | Warner-Lambert Company | Thrombin preparations |
| ZA88227B (en) * | 1987-01-28 | 1988-06-30 | Warner-Lambert Company | Thrombin preparations |
| US4965203A (en) * | 1987-01-28 | 1990-10-23 | Warner-Lambert Company | Purified thrombin preparations |
| EP0317376B2 (de) * | 1987-10-23 | 1996-04-03 | Centre Regional De Transfusion Sanguine De Lille | Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat |
| SU1527261A1 (ru) * | 1988-03-21 | 1989-12-07 | Институт Химической И Биологической Физики Ан Эсср | Способ получени тромбина |
-
1990
- 1990-01-24 IE IE26690A patent/IE73210B1/en not_active IP Right Cessation
-
1991
- 1991-01-23 US US07/644,800 patent/US5151355A/en not_active Expired - Lifetime
- 1991-01-23 CA CA002034826A patent/CA2034826A1/en not_active Abandoned
- 1991-01-23 DE DE69120550T patent/DE69120550D1/de not_active Expired - Lifetime
- 1991-01-23 ZA ZA91500A patent/ZA91500B/xx unknown
- 1991-01-23 JP JP02134891A patent/JP3276964B2/ja not_active Expired - Fee Related
- 1991-01-23 AT AT91100853T patent/ATE140026T1/de not_active IP Right Cessation
- 1991-01-23 EP EP91100853A patent/EP0439156B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2034826A1 (en) | 1991-07-25 |
| DE69120550D1 (de) | 1996-08-08 |
| US5151355A (en) | 1992-09-29 |
| JP3276964B2 (ja) | 2002-04-22 |
| IE73210B1 (en) | 1997-05-07 |
| IE900266A1 (en) | 1991-07-31 |
| ZA91500B (en) | 1991-11-27 |
| EP0439156B1 (de) | 1996-07-03 |
| JPH04211372A (ja) | 1992-08-03 |
| EP0439156A1 (de) | 1991-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE140026T1 (de) | Verfahren zur herstellung von thrombin und danach erhaltene hochgereinigte thrombinzusammensetzung | |
| DE68915675T3 (de) | Verfahren zur Reinigung von Vitamin K-abhängigen Proteinen. | |
| EP0056629B1 (de) | Verfahren zur Reinigung der Blutgerinnungsfaktoren II, VII, IX und/oder X und danach hergestellte Präparationen | |
| EP0391526A3 (de) | Reinigungsverfahren für Antikörper | |
| ATE67247T1 (de) | Verfahren zur raffinierung von kohlenhydraten und bei diesem verfahren verwendbare enzymmischungen. | |
| ATE70301T1 (de) | Gewebeplasminogen-aktivator-mutant, dafuer kodierende rekombinante genetische information und verfahren zur herstellung dieser mutanten, deren verwendung und pharmazeutische zusammensetzungen. | |
| ATE42178T1 (de) | Zusammengesetztes fleischprodukt und verfahren zu dessen herstellung. | |
| ATE59962T1 (de) | Thrombin bindender stoff und verfahren zu seiner herstellung. | |
| DE69330807D1 (de) | Verfahren zur Herstellung von gereinigtem Enzym | |
| ATE56755T1 (de) | Stamm von clostridium acetobutylleum und verfahren zur herstellung desselben. | |
| US4137127A (en) | Process for the preparation of thrombin-like enzymes from snake venoms | |
| ATE121418T1 (de) | Verfahren zur proteinreinigung. | |
| ATE119196T1 (de) | Verfahren zur herstellung einer an faktor-viia angereicherten fraktion und ihre verwendung als arzneimittel. | |
| ATE95836T1 (de) | Zum abbau von glycosaminoglycan faehige enzymzusammensetzung und verfahren zur herstellung dieser zusammensetzung. | |
| ATE84971T1 (de) | Verfahren zur beseitigung von pertussisendotoxin, ein pertussistoxoid und seine herstellung. | |
| ATE270327T1 (de) | Verfahren zur präparation von humanem aktiviertem protein c | |
| EP0883684B1 (de) | Verfahren zur reinigung von thrombinähnlichen proteasen aus schlangengiften | |
| DE68919282D1 (de) | Verfahren zur Herstellung von Cephalosporin und Zwischenverbindungen. | |
| Williams et al. | Purification and properties of a procoagulant from peninsula tiger snake (Notechis ater niger) venom | |
| EP0776969B1 (de) | Verfahren zur Herstellung von Proteinen durch kontrollierte proteolytische spaltung von Pro-Proteinen | |
| Griffith et al. | Fractionation of heparin by affinity chromatography on covalently-bound human α-thrombin | |
| US3711376A (en) | Coagulants | |
| DE3585416D1 (de) | Verfahren zur herstellung eines biologischen stoffes. | |
| DE59308942D1 (de) | Verfahren zur Bestimmung von Fibrinogen | |
| DE3751605D1 (de) | Therapeutisches Blutprodukt, Mittel und Verfahren zu dessen Erzeugung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |